GenomiCare Biotechnology (GC) has launched the GCInsight
A robust and powerful tool designed to help researchers and drug developers understand the distribution of genetic or clinical markers across various types of cancers, and quickly identify indicators with potential clinical value.
GCInsight Standard
Out-of-the-box and easy to access
The built-in standard datasets comprise a range of valuable information, such as gene mutations, mRNA expression, tumor-infiltrating immune cell (TIIC) results, HLA typing, and survival data for both pan-cancer and specific cancer types.
Independent data sources including clinical, genetic and follow-up outcomes
Unified data processing standards
GCInsight Extension
Enriched patient data for a specific cancer type
Supports Integration of client proprietary or third-party public database data
Supports Integration of client proprietary or third-party public database data